Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis

Charles R. Sims; Siraya Jaijakul; John Mohr; Jose Rodriguez; Malcolm Finkelman; Luis Ostrosky-Zeichner

doi:10.1128/JCM.00773-12

Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis

Charles R. Sims, Siraya Jaijakul, John Mohr, Jose Rodriguez, Malcolm Finkelman, Luis Ostrosky-Zeichner

Research output: Contribution to journal › Article

40 Scopus citations

Abstract

The correlation of β-glucan (BG) levels with clinical outcomes in invasive candidiasis (IC) remains unknown. Patients with proven IC were followed prospectively from diagnosis to outcome with twice-weekly serum BG sampling. Correlation of BG with clinical outcome was assessed in each patient. BG levels tend to decrease in successfully treated patients and increase in treatment failures. BG levels may be useful as surrogates for outcome evaluation of IC.

Original language	English (US)
Pages (from-to)	2104-2106
Number of pages	3
Journal	Journal of Clinical Microbiology
Volume	50
Issue number	6
DOIs	https://doi.org/10.1128/JCM.00773-12
State	Published - Jun 2012

ASJC Scopus subject areas

Microbiology (medical)

Access to Document

10.1128/JCM.00773-12

Fingerprint Dive into the research topics of 'Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis'. Together they form a unique fingerprint.

Cite this

@article{7e3b1fee88d14de5b0f8524f7c3f556a,

title = "Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis",

abstract = "The correlation of β-glucan (BG) levels with clinical outcomes in invasive candidiasis (IC) remains unknown. Patients with proven IC were followed prospectively from diagnosis to outcome with twice-weekly serum BG sampling. Correlation of BG with clinical outcome was assessed in each patient. BG levels tend to decrease in successfully treated patients and increase in treatment failures. BG levels may be useful as surrogates for outcome evaluation of IC.",

author = "Sims, {Charles R.} and Siraya Jaijakul and John Mohr and Jose Rodriguez and Malcolm Finkelman and Luis Ostrosky-Zeichner",

year = "2012",

month = jun,

doi = "10.1128/JCM.00773-12",

language = "English (US)",

volume = "50",

pages = "2104--2106",

journal = "Journal of Clinical Microbiology",

issn = "0095-1137",

publisher = "American Society for Microbiology",

number = "6",

}

TY - JOUR

T1 - Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis

AU - Sims, Charles R.

AU - Jaijakul, Siraya

AU - Mohr, John

AU - Rodriguez, Jose

AU - Finkelman, Malcolm

AU - Ostrosky-Zeichner, Luis

PY - 2012/6

Y1 - 2012/6

N2 - The correlation of β-glucan (BG) levels with clinical outcomes in invasive candidiasis (IC) remains unknown. Patients with proven IC were followed prospectively from diagnosis to outcome with twice-weekly serum BG sampling. Correlation of BG with clinical outcome was assessed in each patient. BG levels tend to decrease in successfully treated patients and increase in treatment failures. BG levels may be useful as surrogates for outcome evaluation of IC.

AB - The correlation of β-glucan (BG) levels with clinical outcomes in invasive candidiasis (IC) remains unknown. Patients with proven IC were followed prospectively from diagnosis to outcome with twice-weekly serum BG sampling. Correlation of BG with clinical outcome was assessed in each patient. BG levels tend to decrease in successfully treated patients and increase in treatment failures. BG levels may be useful as surrogates for outcome evaluation of IC.

UR - http://www.scopus.com/inward/record.url?scp=84862059147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862059147&partnerID=8YFLogxK

U2 - 10.1128/JCM.00773-12

DO - 10.1128/JCM.00773-12

M3 - Article

C2 - 22461680

AN - SCOPUS:84862059147

VL - 50

SP - 2104

EP - 2106

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 6

ER -